Commissariat au lobbying du Canada Commissariat au lobbying du Canada

Sélection de la langue

Le Registre des lobbyistes

Sommaire de 12 mois d'activités de lobbying - Lobbyistes salariés d'entreprises

Retour aux résultats de la recherche de 12 mois d'activités de lobbying

Sanofi Pasteur Limited / Matthieu Puyet, Head of Manufacturing & Supply, Canada, Toronto Site Head

Retour aux résultats de la recherche de 12 mois d'activités de lobbying

Adresse et activités de l'entreprise

Sanofi Pasteur Limited - Adresse et activités de l'entreprise

Adresse :

1755 Steeles Avenue West
Toronto, ON  M2R 3T4
Canada

Numéro de téléphone : 416-399-8929

  • Coordonnées dans les versions précédentes
    • 1755 Steeles Avenue West
      Toronto, ON  M2R 3T4
      Canada

      Numéro de téléphone : 416-667-2914

    • 1755 Steeles Avenue West
      Toronto, ON  M2R 3T4
      Canada

      Numéro de téléphone : 416-667-2914

      Numéro de fax : 416-667-2860  

    • 1755 Steeles Avenue West
      Toronto, ON  M2R 3T4
      Canada

      Numéro de téléphone : 416-667-2760

      Numéro de fax : 416-667-2977  


Description des activités :
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Vaccines at Sanofi provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi produces a portfolio of high quality vaccines that matches its areas of expertise and meets public-health demand. The company's heritage, to create vaccines that protect life, dates back more than a century.

  • Descriptions des activités de l'entreprise dans les versions précédentes :
    • Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur produces a portfolio of high quality vaccines that matches its areas of expertise and meets public-health demand. The company's heritage, to create vaccines that protect life, dates back more than a century.
    • Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur, and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers a broad range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development.
    • Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development.
    • Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2009, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
    • The sanofi-aventis Group is one of the world's largest pharmaceutical companies. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
    • The sanofi-aventis Group is one of the world's largest pharmaceutical company, ranked number one in Europe. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2007, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
    • The sanofi-aventis Group is the world's third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi pasteur, the vaccines division of the sanofi-aventis Group, provided more than one billion doses of vaccine in 2006, or about 1.5 million per day, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines, providing protection against 20 infectious diseases.
    • The sanofi-aventis Group is the world's third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class Research & Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi pasteur, the vaccines business of the sanofi-aventis Group, sold nearly a billion doses of vaccine in 2004, making it possible to protect more than 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases.
    • The sanofi-aventis Group is the world's third-largest pharmaceutical company, ranking number one in Europe. Backed by a world-class Research &Development organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi pasteur, the vaccines business of the sanofi-aventis Group, sold nearly a billion doses of vaccine in 2004, making it possible to protect more than 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases.


Charges publiques occupées : Matthieu Puyet


Adresse

Sanofi

46 Avenue de la Grande Armee
Paris  75017

Financement public

Date de la fin du dernier exercice financier complet : 2023-12-31
Liste du financement public
Institution gouvernementale Financement reçu au cours du dernier exercice financier Financement attendu pendant l'exercice financier en cours
Innovation, Sciences et Développement économique Canada (ISDE) 126 775 492,00 $ Oui
Ontario Ministry of Economic Development and Growth 10 000 000,00 $ Oui
Ontario Ministry of Economic Development, Job Creation and Trade 7 000 000,00 $ Oui

  • Financement public dans les versions précédentes

      Liste du financement public
      Date de la fin du dernier exercice financier complet Institution gouvernementale Financement reçu au cours du dernier exercice financier Financement attendu pendant l'exercice financier en cours
      2022-12-31 Innovation, Sciences et Développement économique Canada (ISDE) 39 550 828,00 $ Oui
      2022-12-31 Ontario Ministry of Economic Development and Growth 8 000 000,00 $ Oui
      2022-12-31 Ontario Ministry of Economic Development, Job Creation and Trade 1 000 000,00 $ Oui

Date de la dernière version :